Transcription factors, chromatin and cancer.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 18804550)

Published in Int J Biochem Cell Biol on September 02, 2008

Authors

James L Thorne1, Moray J Campbell, Bryan M Turner

Author Affiliations

1: University of Birmingham Medical School, Edgbaston, Birmingham, B15 2TT, UK.

Articles citing this

Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci U S A (2010) 2.47

The cardiac transcription network modulated by Gata4, Mef2a, Nkx2.5, Srf, histone modifications, and microRNAs. PLoS Genet (2011) 1.69

The steroid hormone ecdysone functions with intrinsic chromatin remodeling factors to control female germline stem cells in Drosophila. Cell Stem Cell (2010) 1.23

Transcription-independent heritability of induced histone modifications in the mouse preimplantation embryo. PLoS One (2009) 1.00

Transcription factor co-repressors in cancer biology: roles and targeting. Int J Cancer (2010) 0.98

Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis (2010) 0.95

Effects of endocrine disruptors on imprinted gene expression in the mouse embryo. Epigenetics (2011) 0.93

Formation of stress-specific p53 binding patterns is influenced by chromatin but not by modulation of p53 binding affinity to response elements. Nucleic Acids Res (2010) 0.84

Epigenetic transcriptional regulation of the growth arrest-specific gene 1 (Gas1) in hepatic cell proliferation at mononucleosomal resolution. PLoS One (2011) 0.84

A phylogenetic study of SPBP and RAI1: evolutionary conservation of chromatin binding modules. PLoS One (2013) 0.80

FISH Oracle 2: a web server for integrative visualization of genomic data in cancer research. J Clin Bioinforma (2014) 0.78

VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription. Epigenetics (2015) 0.77

Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTR. Virology (2015) 0.76

Interaction between c-jun and androgen receptor determines the outcome of taxane therapy in castration resistant prostate cancer. PLoS One (2013) 0.75

Articles by these authors

The histone modification pattern of active genes revealed through genome-wide chromatin analysis of a higher eukaryote. Genes Dev (2004) 7.57

Epigenetic characterization of the early embryo with a chromatin immunoprecipitation protocol applicable to small cell populations. Nat Genet (2006) 3.44

Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr Opin Genet Dev (2006) 2.49

Immunoprecipitation of native chromatin: NChIP. Methods (2003) 2.27

Dosage compensation in the mouse balances up-regulation and silencing of X-linked genes. PLoS Biol (2007) 2.06

Regulation of the human p21(waf1/cip1) gene promoter via multiple binding sites for p53 and the vitamin D3 receptor. Nucleic Acids Res (2006) 1.89

Stress-induced transcription of satellite III repeats. J Cell Biol (2003) 1.86

Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. J Biol Chem (2006) 1.82

A unified phylogeny-based nomenclature for histone variants. Epigenetics Chromatin (2012) 1.82

Histone modifications in Arabidopsis- high methylation of H3 lysine 9 is dispensable for constitutive heterochromatin. Plant J (2003) 1.69

Autocrine metabolism of vitamin D in normal and malignant breast tissue. Clin Cancer Res (2005) 1.58

Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J Steroid Biochem Mol Biol (2005) 1.45

Human class I histone deacetylase complexes show enhanced catalytic activity in the presence of ATP and co-immunoprecipitate with the ATP-dependent chaperone protein Hsp70. J Biol Chem (2002) 1.35

Molecular and cytogenetic analysis of the spreading of X inactivation in X;autosome translocations. Hum Mol Genet (2002) 1.32

Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food (2004) 1.26

Epigenome changes in active and inactive polycomb-group-controlled regions. EMBO Rep (2004) 1.25

The vitamin D receptor in cancer. Proc Nutr Soc (2008) 1.22

Relative overexpression of X-linked genes in mouse embryonic stem cells is consistent with Ohno's hypothesis. Nat Genet (2011) 1.22

Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells. Clin Cancer Res (2006) 1.22

Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells. Oncogene (2004) 1.20

Vitamin D receptor signaling mechanisms: integrated actions of a well-defined transcription factor. Steroids (2012) 1.18

Developmental timing in Dictyostelium is regulated by the Set1 histone methyltransferase. Dev Biol (2006) 1.15

An increasingly complex code. J Clin Invest (2002) 1.13

KDM6B/JMJD3 histone demethylase is induced by vitamin D and modulates its effects in colon cancer cells. Hum Mol Genet (2011) 1.10

Immunostaining of modified histones defines high-level features of the human metaphase epigenome. Genome Biol (2010) 1.07

Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs (2005) 1.06

Epigenetic engineering: histone H3K9 acetylation is compatible with kinetochore structure and function. J Cell Sci (2012) 1.03

Epigenetic control of a VDR-governed feed-forward loop that regulates p21(waf1/cip1) expression and function in non-malignant prostate cells. Nucleic Acids Res (2010) 1.03

Pituitary tumor transforming gene binding factor: a new gene in breast cancer. Cancer Res (2010) 1.02

Genes are often sheltered from the global histone hyperacetylation induced by HDAC inhibitors. PLoS One (2012) 1.02

Transcription-independent heritability of induced histone modifications in the mouse preimplantation embryo. PLoS One (2009) 1.00

X-linked genes in female embryonic stem cells carry an epigenetic mark prior to the onset of X inactivation. Hum Mol Genet (2003) 1.00

Identification of VDR-responsive gene signatures in breast cancer cells. Oncology (2007) 0.99

Vitamin D has wide regulatory effects on histone demethylase genes. Cell Cycle (2012) 0.99

Transcription factor co-repressors in cancer biology: roles and targeting. Int J Cancer (2010) 0.98

Vitamin D status and breast cancer risk. Anticancer Res (2006) 0.95

Elevated NCOR1 disrupts PPARalpha/gamma signaling in prostate cancer and forms a targetable epigenetic lesion. Carcinogenesis (2010) 0.95

Undifferentiated embryonic cell transcription factor 1 regulates ESC chromatin organization and gene expression. Stem Cells (2010) 0.95

Epigenetic corruption of VDR signalling in malignancy. Anticancer Res (2006) 0.95

Elevated NCOR1 disrupts a network of dietary-sensing nuclear receptors in bladder cancer cells. Carcinogenesis (2009) 0.94

Inhibition of Vitamin D3 metabolism enhances VDR signalling in androgen-independent prostate cancer cells. J Steroid Biochem Mol Biol (2006) 0.94

Antiproliferative signalling by 1,25(OH)2D3 in prostate and breast cancer is suppressed by a mechanism involving histone deacetylation. Recent Results Cancer Res (2003) 0.94

The histone deacetylase inhibitor sodium valproate causes limited transcriptional change in mouse embryonic stem cells but selectively overrides Polycomb-mediated Hoxb silencing. Epigenetics Chromatin (2013) 0.91

Recruitment of NCOR1 to VDR target genes is enhanced in prostate cancer cells and associates with altered DNA methylation patterns. Carcinogenesis (2012) 0.91

Inhibition of histone deacetylases alters allelic chromatin conformation at the imprinted U2af1-rs1 locus in mouse embryonic stem cells. J Biol Chem (2002) 0.91

Memorable transcription. Nat Cell Biol (2003) 0.90

Met receptor signaling: a key effector in esophageal adenocarcinoma. Clin Cancer Res (2006) 0.89

Serum microRNA expression patterns that predict early treatment failure in prostate cancer patients. Oncotarget (2014) 0.89

Design principles of nuclear receptor signaling: how complex networking improves signal transduction. Mol Syst Biol (2010) 0.88

Targeting 1alpha,25-dihydroxyvitamin D3 antiproliferative insensitivity in breast cancer cells by co-treatment with histone deacetylation inhibitors. J Steroid Biochem Mol Biol (2004) 0.87

Altered histone modifications in cancer. Adv Exp Med Biol (2013) 0.87

Analysis of normal-tumour tissue interaction in tumours: prediction of prostate cancer features from the molecular profile of adjacent normal cells. PLoS One (2011) 0.86

Epigenetic distortion to VDR transcriptional regulation in prostate cancer cells. J Steroid Biochem Mol Biol (2012) 0.84

A new map for navigating the yeast epigenome. Cell (2005) 0.84

Elevated FOSB-expression; a potential marker of valproate sensitivity in AML. Br J Haematol (2008) 0.83

Differential loss of histone H3 isoforms mono-, di- and tri-methylated at lysine 4 during X-inactivation in female embryonic stem cells. Biol Chem (2008) 0.81

The Interactions of microRNA and Epigenetic Modifications in Prostate Cancer. Cancers (Basel) (2013) 0.81

Acetylation of core histones in response to HDAC inhibitors is diminished in mitotic HeLa cells. Exp Cell Res (2010) 0.80

Epigenetic repression of transcription by the Vitamin D3 receptor in prostate cancer cells. J Steroid Biochem Mol Biol (2004) 0.79

Mechanisms of decreased Vitamin D 1alpha-hydroxylase activity in prostate cancer cells. Mol Cell Endocrinol (2004) 0.79

Cooperative behavior of the nuclear receptor superfamily and its deregulation in prostate cancer. Carcinogenesis (2013) 0.78

Human CD34+ hematopoietic progenitor cells hyperacetylate core histones in response to sodium butyrate, but not trichostatin A. Exp Cell Res (2002) 0.78

Simplifying a complex code. Nat Struct Mol Biol (2008) 0.77

VDR regulation of microRNA differs across prostate cell models suggesting extremely flexible control of transcription. Epigenetics (2015) 0.77

Gene regulatory scenarios of primary 1,25-dihydroxyvitamin d3 target genes in a human myeloid leukemia cell line. Cancers (Basel) (2013) 0.76

Regulation of CYP3A4 and CYP3A5 expression and modulation of "intracrine" metabolism of androgens in prostate cells by liganded vitamin D receptor. Mol Cell Endocrinol (2012) 0.76

Vitamin D receptor and RXR in the post-genomic era. J Cell Physiol (2015) 0.76

Vitamin D and p53—differentiating their relationship in AML. Cancer Biol Ther (2010) 0.75